Hirdetés

2024. május 5., vasárnap

Gyorskeresés

Hozzászólások

(#78046) Floyd80


Floyd80
addikt

Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says - CNN

Majd a Pampers mellé is ez jár majd.

Johnson & Johnson's Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% effective against severe disease, the company announced Friday.

And, unlike the Pfizer and Moderna vaccines, it does not have to be stored in freezers. It can be stored for three months at refrigerator temperatures of 36 degrees to 46 degrees Fahrenheit.

Johnson & Johnson uses a weakened common cold virus, known as adenovirus, to carry genetic instructions into the body to prompt an immune response.

"A vaccine that's inexpensive, that's a single dose, and that has no cold chain requirements -- that's pretty good," Fauci told CNN.

Johnson & Johnson has said it's on track to produce a billion doses worldwide.

"Felesleges szigetelni a nyílászárókat, ha az ereszcsatornán szökik a meleg."

Copyright © 2000-2024 PROHARDVER Informatikai Kft.